Por: MarketWatch Business November 26, 2022
Rosenberg has been interviewed many times by Barron’s and has made some prescient calls. In late 2011, he compared (MSFT) favorably to (IBM), which had then drawn a big investment from (BRK.A). “Warren Buffett came pretty late to the IBM party,” he said. Microsoft is up tenfold since then, while IBM stock is in the red. Buffett subsequently gave up on Big Blue and sold Berkshire’s stake. Rosenberg follows the markets closely and now is... + full article
MarketWatch USA Business November 26, 2022
Rosenberg has been interviewed many times by Barron’s and has made some prescient calls. In late 2011, he compared (MSFT) favorably to (IBM), which had then drawn a big investment from (BRK.A). “Warren Buffett came pretty late to the IBM party,” he said. Microsoft is up... + más
Alphabet and Pfizer Stock Look Like Buys, Says This Longtime Market Maven | MarketWatch
Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue hit from generics | CNBC
Forbes USA Business November 15, 2022
Updated Nov 15, 2022, 02:29pm ESTTopline TCI Fund Management, the activist hedge fund helmed by U.K. billionaire Christopher Hohn, touted a massive stake in Google parent Alphabet on Tuesday as he called on the company to cut costs by reducing its head count and paying workers... + más
Billionaire hedge fund founders are readying their firms to outlast them. Here's the next generation of leaders as industry titans like Ray Dalio step back. | Business Insider
Activist investor TCI calls on Google parent Alphabet to slash costs | Fox Business
CNBC USA Health November 02, 2022
Pfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021.John Thys AFP Getty Images... + más
Pfizer raises 2022 earnings guidance, beats third-quarter expectations | CNBC
Pfizer climbs on strong Q3 results, raised outlook | MarketWatch
ABC News USA Business November 01, 2022
Pfizer’s COVID-19 treatment helped the pharmaceutical giant balance tumbling international sales for its vaccine and top third-quarter expectations.The pill treatment Paxlovid brought in $7.5 billion in sales in the quarter and has generated more than $17 billion so far this... + más
Covid-19 treatment Paxlovid can interact with common heart medications, doctors warn | CNN
CNBC USA Health November 01, 2022
In this articleVials containing the Pfizer/BioNtech vaccine against the coronavirus disease (COVID-19) are displayed before being used at a mobile vaccine clinic, in Valparaiso, Chile, January 3, 2022.Rodrigo Garrido Reuters on Tuesday raised its 2022 earnings guidance after... + más
Fox Business USA Business October 22, 2022
Fox News contributor Dr. Janette Nesheiwat discusses Pfizer’s new anti-viral COVID-19 pill and the importance of early treatment. has revealed the price it is eyeing in the U.S. for its adult COVID-19 vaccine on the commercial market. Ticker Security Last Change Change %... + más
Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate
Pfizer says COVID-19 vaccine will cost $110-$130 per dose | ABC News
The Advocate USA Crime October 10, 2022
vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine.Moderna said Friday that Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed... + más
Moderna is suing Pfizer over its coronavirus vaccine | The Verge
Moderna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | Los Angeles Times
About iurex | Privacy Policy | Disclaimer |